SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,033.78 1,109.10
( 1.54%)

Global Indices

Nasdaq

51,875.59 199.64
(0.39%)

Dow Jones

7,829.18 -3.36
(-0.04%)

Hang Seng

67,705.85 -1,325.07
(-1.92%)

Nikkei 225

10,644.02 91.97
(0.87%)

Forex

USD-INR

96.46 -0.32
(-0.33%)

EUR-INR

108.04 -0.35
(-0.32%)

GBP-INR

127.62 -0.24
(-0.19%)

JPY-INR

0.61 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

356.2353295

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

56.09

10102.59

EPS(TTM)

Face Value()

Div & Yield %

19.54

0.46

Back

Swati Projects reports consolidated net profit of Rs 0.71 crore in the June 2026 quarter

Aug 13,2026

Net profit of Swati Projects reported to Rs 0.71 crore in the quarter ended June 2026 as against net loss of Rs 0.65 crore during the previous quarter ended June 2025. Sales rose 166.67% to Rs 1.68 crore in the quarter ended June 2026 as against Rs 0.63 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.68	0.63	167
OPM %	52.38	-90.48	-
PBDT	0.88	-0.57	LP
PBT	0.85	-0.58	LP
NP	0.71	-0.65	LP

73,033.78 1,109.10 ( 1.54%)

51,875.59 199.64 (0.39%)

7,829.18 -3.36 (-0.04%)

67,705.85 -1,325.07 (-1.92%)

10,644.02 91.97 (0.87%)

96.46 -0.32 (-0.33%)

108.04 -0.35 (-0.32%)

127.62 -0.24 (-0.19%)

0.61 0.00 (-0.50%)